Literature DB >> 1733640

Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression.

A Lloyd1, I Hickie, C Hickie, J Dwyer, D Wakefield.   

Abstract

The chronic fatigue syndrome (CFS) is characterized by severe persistent fatigue and neuropsychiatric symptoms. It has been proposed that the abnormalities in cell-mediated immunity which have been documented in patients with CFS may be attributable to a clinical depression, prevalent in patients with this disorder. Cell-mediated immune status was evaluated in patients with carefully defined CFS and compared with that of matched subjects with major depression (non-melancholic, non-psychotic) as well as healthy control subjects. Patients with CFS demonstrated impaired lymphocyte responses to phytohaemagglutinin (PHA) stimulation, and reduced or absent delayed-type hypersensitivity (DTH) skin responses when compared either with subjects with major depression or with healthy control subjects (P less than 0.05 for each analysis). Although depression is common in patients with CFS, the disturbances of cell-mediated immunity in this disorder differ in prevalence and magnitude from those associated with major depression. These observations strengthen the likelihood of a direct relationship between abnormal cell-mediated immunity and the etiology of CFS.

Entities:  

Mesh:

Year:  1992        PMID: 1733640      PMCID: PMC1554231          DOI: 10.1111/j.1365-2249.1992.tb06416.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Immunological abnormalities in the chronic fatigue syndrome.

Authors: 
Journal:  Med J Aust       Date:  1990-01-01       Impact factor: 7.738

2.  Immunologic abnormalities in chronic fatigue syndrome.

Authors:  N G Klimas; F R Salvato; R Morgan; M A Fletcher
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Immunological reason for chronic ill health after infectious mononucleosis.

Authors:  T J Hamblin; J Hussain; A N Akbar; Y C Tang; J L Smith; D B Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-09

4.  Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A.

Authors:  W T Kniker; C T Anderson; J L McBryde; M Roumiantzeff; B Lesourd
Journal:  Ann Allergy       Date:  1984-02

5.  Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. A 31P nuclear magnetic resonance study.

Authors:  D L Arnold; P J Bore; G K Radda; P Styles; D J Taylor
Journal:  Lancet       Date:  1984-06-23       Impact factor: 79.321

6.  Lymphocyte function in major depressive disorder.

Authors:  S J Schleifer; S E Keller; A T Meyerson; M J Raskin; K L Davis; M Stein
Journal:  Arch Gen Psychiatry       Date:  1984-05

Review 7.  The interferons.

Authors:  J L Toy
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

8.  Impaired lymphocyte function in depressive illness.

Authors:  Z Kronfol; J Silva; J Greden; S Dembinski; R Gardner; B Carroll
Journal:  Life Sci       Date:  1983-07-18       Impact factor: 5.037

9.  Involvement of interferon in virus-induced lymphopenia.

Authors:  A Schattner; A Meshorer; D Wallach
Journal:  Cell Immunol       Date:  1983-07-01       Impact factor: 4.868

10.  Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome.

Authors:  A R Lloyd; S C Gandevia; J P Hales
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

View more
  7 in total

Review 1.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

3.  Chronic fatigue syndrome. Immunological findings vary between populations.

Authors:  N C Abbot; V A Spence; J G Lowe; R C Potts; A H Hassan; J J Belch; J S Beck
Journal:  BMJ       Date:  1994-05-14

4.  Lymphocyte proliferation is associated with gender, caregiving, and psychosocial variables in older adults.

Authors:  J M Scanlan; P P Vitaliano; J Zhang; M Savage; H D Ochs
Journal:  J Behav Med       Date:  2001-12

5.  Chronic fatigue syndrome: have flawed assumptions been derived from treatment-based studies?

Authors:  J A Richman; J A Flaherty; K M Rospenda
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

6.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

7.  Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Ekua W Brenu; Mieke L van Driel; Donald R Staines; Kevin J Ashton; Sharni L Hardcastle; James Keane; Lotti Tajouri; Daniel Peterson; Sandra B Ramos; Sonya M Marshall-Gradisnik
Journal:  J Transl Med       Date:  2012-05-09       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.